tiprankstipranks
Advertisement
Advertisement

PRQR Stock Latest News

ProQR Therapeutics price target lowered to $10 from $14 at Raymond James
The FlyProQR Therapeutics price target lowered to $10 from $14 at Raymond James
3d ago
PRQR
ProQR Raises $59 Million in Equity Offering and Eli Lilly Private Placement
PremiumCompany Announcements
ProQR Raises $59 Million in Equity Offering and Eli Lilly Private Placement
3d ago
6K
PRQR
ProQR Therapeutics price target lowered to $10 from $11 at JonesResearch
PremiumThe Fly
ProQR Therapeutics price target lowered to $10 from $11 at JonesResearch
3d ago
PRQR
ProQR Therapeutics price target lowered to $3 from $4 at Chardan
PremiumThe Fly
ProQR Therapeutics price target lowered to $3 from $4 at Chardan
4d ago
PRQR
ProQR Reports Positive Phase 1 Data Validating Axiomer RNA Editing Platform
PremiumCompany Announcements
ProQR Reports Positive Phase 1 Data Validating Axiomer RNA Editing Platform
4d ago
6K
PRQR
ProQR Therapeutics prices 27.62M shares at $1.81 in registered direct offering
PremiumThe FlyProQR Therapeutics prices 27.62M shares at $1.81 in registered direct offering
4d ago
LLY
PRQR
ProQR Therapeutics announces positive Phase 1 data for AX-0810
Premium
The Fly
ProQR Therapeutics announces positive Phase 1 data for AX-0810
4d ago
PRQR
ProQR Shareholders Approve Capital Increase, Board Changes at 2026 AGM
Premium
Company Announcements
ProQR Shareholders Approve Capital Increase, Board Changes at 2026 AGM
27d ago
6K
PRQR
ProQR: Buy Rating Reiterated as Axiomer Pipeline Progress and Upcoming Catalysts Support Unchanged $12 Price Target
PremiumRatings
ProQR: Buy Rating Reiterated as Axiomer Pipeline Progress and Upcoming Catalysts Support Unchanged $12 Price Target
2M ago
PRQR
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances
PremiumCompany Announcements
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances
2M ago
6K
PRQR
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position
PremiumCompany Announcements
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position
2M ago
6K
PRQR
ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders
PremiumCompany Announcements
ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders
2M ago
6K
PRQR
ProQR Nominates Boehringer Ingelheim CMO Lykke Hinsch Gylvin to Board to Support Next Growth Phase
PremiumCompany AnnouncementsProQR Nominates Boehringer Ingelheim CMO Lykke Hinsch Gylvin to Board to Support Next Growth Phase
2M ago
6K
PRQR
ProQR Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
ProQR Therapeutics management to meet with Cantor Fitzgerald
3M ago
PRQR
ProQR Therapeutics management to meet with Oppenheimer
Premium
The Fly
ProQR Therapeutics management to meet with Oppenheimer
3M ago
PRQR
ProQR Details Axiomer Pipeline Expansion and New Liver and Genetic Disease Programs
PremiumCompany Announcements
ProQR Details Axiomer Pipeline Expansion and New Liver and Genetic Disease Programs
3M ago
6K
PRQR
ProQR Partners with Ginkgo Bioworks, Launches AI Advisory Board to Drive Axiomer RNA Drug Discovery
PremiumCompany Announcements
ProQR Partners with Ginkgo Bioworks, Launches AI Advisory Board to Drive Axiomer RNA Drug Discovery
3M ago
6K
PRQR
Oppenheimer Predicts Up to ~560% Rally for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Oppenheimer Predicts Up to ~560% Rally for These 2 ‘Strong Buy’ Stocks
3M ago
PRQR
SERV
ProQR Sets April 8 Virtual Investor Event to Spotlight Axiomer RNA Editing Pipeline
PremiumCompany Announcements
ProQR Sets April 8 Virtual Investor Event to Spotlight Axiomer RNA Editing Pipeline
3M ago
6K
PRQR
ProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty
PremiumCompany AnnouncementsProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty
4M ago
PRQR
ProQR Posts 2025 Results as Axiomer RNA Editing Pipeline Advances and Cash Runway Extends to Mid-2027
Premium
Company Announcements
ProQR Posts 2025 Results as Axiomer RNA Editing Pipeline Advances and Cash Runway Extends to Mid-2027
4M ago
6K
PRQR
ProQR Therapeutics assumed with an Outperform at Oppenheimer
Premium
The Fly
ProQR Therapeutics assumed with an Outperform at Oppenheimer
4M ago
PRQR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >